Financial News
Biocryst Pharma Inc (NQ: BCRX )
8.100
+0.170
(+2.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Biocryst Pharma Inc
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for BioCryst Pharma's Future
May 04, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://g.foolcdn.com/editorial/images/730749/pig-taking-flight.jpg)
![](/next-assets/images/schema-image-default.png)
Recap: BioCryst Pharma Q1 Earnings
May 03, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/bcrx-1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/04/18/ericsson_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/721904/physician-monitoring-patients-onscreen-vitals.jpg)
![](https://g.foolcdn.com/editorial/images/721631/scientists-in-a-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/22/bcrx_logo_light__fc1e55ad8ce820ca412a5e3539641bf0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/21/image14.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Biocryst Pharmaceuticals's Earnings Outlook
February 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/15/bcrx_logo_light__fc1e55ad8ce820ca412a5e3539641bf0.png?width=1200&height=800&fit=crop)
BioCryst Shelves Development Of Rare Blood Disorder Candidate
December 15, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/21/analysis-g1eddf33c2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/09/image15_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29088.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/09/analysis-g026b5b83f_1920.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/09/tsla1600.png)
![](https://investorplace.com/wp-content/uploads/2019/09/cars.jpg)
![](https://investorplace.com/wp-content/uploads/2019/09/pills-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/15/image-western_digital.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image-vf_corp.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29074.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29034.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image29.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.